We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Published in Oncology

Journal Scan / Research · January 03, 2019

Improved HCT Outcomes With One or Two Cycles of HDAC Consolidation Therapy

Clinical Lymphoma, Myeloma & Leukemia


Additional Info

Disclosure statements are available on the authors' profiles:

Clinical Lymphoma, Myeloma & Leukemia
Impact of Consolidation Cycles Before Allogeneic Hematopoietic Cell Transplantation for Acute Myeloid Leukemia in First Complete Remission
Clin Lymphoma Myeloma Leuk 2018 Dec 01;18(12)e529-e535, YJ Lee, DW Baek, JS Ahn, SY Ahn, SH Jung, DH Yang, JJ Lee, HJ Kim, JY Ham, JS Suh, SK Sohn, JH Moon

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading